Hologic Announces Financial Results for First Quarter of Fiscal 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Hologic (HOLX) Tops Q1 EPS by 69c, Revenues Beat; Offers 2Q EPS/Revenue Guidance Above Consensus
January 27, 2021 4:06 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $2.86, $0.69 better than the analyst estimate of $2.17. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.4 billion.
Revenue of $1.61 Billion Increases 89.3%, 86.5% in Constant Currency Organic Revenue Increases 107.0%, 104.0% in Constant Currency Company Posts GAAP Diluted EPS of $2.50, Non-GAAP Diluted EPS of $2.86Hologic had a strong start to fiscal 2021 across... More
